SO
79
4
CRM
47
2
EQR
67
5
ICE
49
-4
ESS
70
2
EXPE
61
5
UNH
56
4
CTAS
55
3
M
48
6
SEE
55
7
TAP
50
2
GIS
61
3
PBI
49
10
HSY
53
2
DAL
76
3
QCOM
80
9
HRB
73
2
K
51
10
AAP
29
2
CHRW
64
16
SO
79
4
CRM
47
2
EQR
67
5
ICE
49
-4
ESS
70
2
EXPE
61
5
UNH
56
4
CTAS
55
3
M
48
6
SEE
55
7
TAP
50
2
GIS
61
3
PBI
49
10
HSY
53
2
DAL
76
3
QCOM
80
9
HRB
73
2
K
51
10
AAP
29
2
CHRW
64
16
Financhill
Back

Arcus Biosciences Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
41

RCUS
Arcus Biosciences

Last Price:
15.66
Seasonality Move:
-13.65%
Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
14.71
Seasonality Move:
10.94%
Sell
41
Arcus Biosciences (RCUS) is a Sell

Is Arcus Biosciences a Buy, Sell or Hold?

  • The current Arcus Biosciences [RCUS] share price is $15.50. The Score for RCUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RCUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.02. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCUS Stock Price Chart

What is Arcus Biosciences's stock price today?

  • The Arcus Biosciences share price today is $15.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCUS is experiencing slight selling pressure.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight selling pressure.

RCUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 44.6 Sell
Chaikin Money Flow: -102170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.03 - 17.49) Sell
Bollinger Bands (100): (15.55 - 18.61) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 46.14 Sell
Chaikin Money Flow: -382610 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.97 - 15.69) Sell
Bollinger Bands (100): (14.09 - 16.21) Sell

RCUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.38 Buy
20-day SMA: 15.83 Sell
50-day SMA: 17.34 Sell
200-day SMA: 17.39 Sell
8-day EMA: 15.42 Buy
20-day EMA: 15.84 Sell
50-day EMA: 16.53 Sell
200-day EMA: 17.63 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.99 Buy
20-day SMA: 15.29 Sell
50-day SMA: 15.6 Sell
200-day SMA: 14.25 Buy
8-day EMA: 15.09 Sell
20-day EMA: 15.25 Sell
50-day EMA: 15.3 Sell
200-day EMA: 14.61 Buy

Arcus Biosciences Earnings Growth & RCUS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.21 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Arcus Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):